Remote Monitoring for Lifestyle Changes in Patients with Lung Cancer Related Fatigue
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 21-013228
NCT ID: NCT05407038
Sponsor Protocol Number: 21-013228
About this study
The purpose of this study is to test the effectiveness of a remote monitoring program with health coaching for patients with cancer related fatigue.
The primary objective is to assess the effect of the remote-monitoring program on patient reported fatigue by administering the Brief Fatigue Inventory and the Cancer Fatigue Scale/ MFSI-SF. Secondary objective is to assess the effect of the program on quality of life by administering the LASA questionnaire.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Age ≥ 18 years.
- Diagnosed with advanced NSCLC being treated with any line of non-curative intent, systemic treatment.
- Eastern Cooperative Oncology Group (ECOG) Performance Status from 0 (asymptomatic) to 2.
- The ability to read and respond to questions in English or Spanish.
- Receiving primary cancer care at Mayo Clinic, Rochester or MCHS.
- Life expectancy at least 6 months.
Exclusion Criteria:
- Individuals < 18 years.
- Patients wioth cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation.
Eligibility last updated 12/21/21. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Roberto Benzo, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available